Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

CONN’S Inc. (CONN): Christian Leone’s Luxor Capital Goes Activist as it Continues to Buy Stock (1.95 Million Shares on Monday)

As reported yesterday, Christian Leone’s Luxor Capital Group has been boosting its exposure to CONN’S, Inc. (NASDAQ:CONN) for quite some time. According to its latest filings with the Securities and Exchange Commission, Luxor has yet again augmented its stake in the company, and gone activist on it –although it did not announce any plans in relation to the company. Through several transactions, the fund acquired approximately 1.95 million shares of CONN’S, Inc. (NASDAQ:CONN), for prices ranging from $29.39 per share to $30.78 per share. Following these purchases, Luxor may be deemed beneficial ownership of 7.58 million shares of Common Stock, which represent approximately 20.9% of the outstanding shares of Common Stock.

Christian Leone

Luxor Capital Group had trimmed its stake in CONN’S, Inc. (NASDAQ:CONN) by 16% over the second quarter of the year. However, over the second half of the year, it has more than doubled its exposure to the company (the fund had disclosed ownership of around 2.94 million shares in its latest 13F filing).

CONN’S, Inc. (NASDAQ:CONN) stock is down more than 61% year-to-date, and almost 38% since the end of the second quarter, so one can understand why Luxor sees a chance to buy. Currently valued at 11.6 times the company’s earnings, this $1.1 billion market cap specialty retailer of branded consumer durable goods trades at a 75% discount to the specialty retailers’ industry average.

In addition to Mr. Leone’s bullishness, most of the top institutional investors in CONN’S, Inc. (NASDAQ:CONN) augmented their involvement in the company over the second quarter. David Einhorn’s Greenlight Capital added 7% to its holdings and now owns 3.5 million shares, while Daniel Gold’s QVT Financial upped its stake by 150% to roughly 762,000 shares.

As outlined in a previous article, CONN’S, Inc. (NASDAQ:CONN) still looks like an attractive investment, despite its declining stock price (and maybe, to some extent, because of it). The company reported revenue of $353 million for the second quarter, up from $271 million a year ago, and solid same store growth in most of its categories. However, earnings declined to $0.48 per share, from $0.52 last year. From a qualitative point of view the retailer also looks well positioned. The company opened 14 stores during the last few months.

In addition to being a retailer, the company provides credit for its clients. Many analysts do not like this part of its business, as it creates trouble at times. For the second quarter, the revenues from credits rose 37.8% to $64.3 million, with the portfolio balance surging by almost 40% to $1.18 billion. Nonetheless, the provision for bad debts also grew, to $18.3 million, mostly on the back of higher than expected delinquency.

Disclosure: Javier Hasse holds no positions in any stocks or funds mentioned

Warren Buffett and BillionairesFree Report: Warren Buffett and 12 Billionaires Are Crazy About These 7 Stocks

Let Warren Buffett, David Einhorn, George Soros, and David Tepper WORK FOR YOU. If you want to beat the low cost index funds by an average of 6 percentage points per year look no further than Warren Buffett’s stock picks. That’s the margin Buffett’s stock picks outperformed the market since 2008. In this free report, Insider Monkey’s market beating research team identified 7 stocks Warren Buffett and 12 other billionaires are crazy about. CLICK HERE NOW for all the details.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!